nodes	percent_of_prediction	percent_of_DWPC	metapath
Brimonidine—Tizanidine—CYP1A2—chronic obstructive pulmonary disease	0.00992	0.501	CrCbGaD
Brimonidine—Clonidine—CYP1A1—chronic obstructive pulmonary disease	0.00503	0.254	CrCbGaD
Brimonidine—Clonidine—CYP1A2—chronic obstructive pulmonary disease	0.00485	0.245	CrCbGaD
Brimonidine—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00185	0.00222	CcSEcCtD
Brimonidine—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00185	0.00222	CcSEcCtD
Brimonidine—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00185	0.00222	CcSEcCtD
Brimonidine—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00185	0.00222	CcSEcCtD
Brimonidine—Diabetes mellitus—Prednisolone—chronic obstructive pulmonary disease	0.00184	0.00221	CcSEcCtD
Brimonidine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00184	0.00221	CcSEcCtD
Brimonidine—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.00183	0.0022	CcSEcCtD
Brimonidine—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.00183	0.0022	CcSEcCtD
Brimonidine—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00181	0.00217	CcSEcCtD
Brimonidine—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00181	0.00217	CcSEcCtD
Brimonidine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00181	0.00217	CcSEcCtD
Brimonidine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00181	0.00217	CcSEcCtD
Brimonidine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.0018	0.00216	CcSEcCtD
Brimonidine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.0018	0.00216	CcSEcCtD
Brimonidine—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00179	0.00215	CcSEcCtD
Brimonidine—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00179	0.00215	CcSEcCtD
Brimonidine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.00179	0.00215	CcSEcCtD
Brimonidine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.00179	0.00215	CcSEcCtD
Brimonidine—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00179	0.00215	CcSEcCtD
Brimonidine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00179	0.00214	CcSEcCtD
Brimonidine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00177	0.00213	CcSEcCtD
Brimonidine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00177	0.00212	CcSEcCtD
Brimonidine—Arthropathy—Prednisone—chronic obstructive pulmonary disease	0.00176	0.00212	CcSEcCtD
Brimonidine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00176	0.00211	CcSEcCtD
Brimonidine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00176	0.00211	CcSEcCtD
Brimonidine—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00175	0.00211	CcSEcCtD
Brimonidine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00175	0.0021	CcSEcCtD
Brimonidine—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00175	0.0021	CcSEcCtD
Brimonidine—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00175	0.0021	CcSEcCtD
Brimonidine—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00175	0.0021	CcSEcCtD
Brimonidine—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00174	0.00209	CcSEcCtD
Brimonidine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00173	0.00208	CcSEcCtD
Brimonidine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00173	0.00207	CcSEcCtD
Brimonidine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.0017	0.00204	CcSEcCtD
Brimonidine—Hypercholesterolaemia—Prednisone—chronic obstructive pulmonary disease	0.0017	0.00204	CcSEcCtD
Brimonidine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.00169	0.00203	CcSEcCtD
Brimonidine—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.00169	0.00203	CcSEcCtD
Brimonidine—Cataract—Prednisone—chronic obstructive pulmonary disease	0.00169	0.00202	CcSEcCtD
Brimonidine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00168	0.00202	CcSEcCtD
Brimonidine—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00165	0.00198	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00164	0.00197	CcSEcCtD
Brimonidine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00163	0.00196	CcSEcCtD
Brimonidine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00162	0.00194	CcSEcCtD
Brimonidine—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.0016	0.00192	CcSEcCtD
Brimonidine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00159	0.0019	CcSEcCtD
Brimonidine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00158	0.00189	CcSEcCtD
Brimonidine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00158	0.00189	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00156	0.00187	CcSEcCtD
Brimonidine—Cough—Formoterol—chronic obstructive pulmonary disease	0.00156	0.00187	CcSEcCtD
Brimonidine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00156	0.00187	CcSEcCtD
Brimonidine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00154	0.00185	CcSEcCtD
Brimonidine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00154	0.00185	CcSEcCtD
Brimonidine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00154	0.00185	CcSEcCtD
Brimonidine—Cough—Montelukast—chronic obstructive pulmonary disease	0.00152	0.00183	CcSEcCtD
Brimonidine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00152	0.00182	CcSEcCtD
Brimonidine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00152	0.00182	CcSEcCtD
Brimonidine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00152	0.00182	CcSEcCtD
Brimonidine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00152	0.00182	CcSEcCtD
Brimonidine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00152	0.00182	CcSEcCtD
Brimonidine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00152	0.00182	CcSEcCtD
Brimonidine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00151	0.00182	CcSEcCtD
Brimonidine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00151	0.00182	CcSEcCtD
Brimonidine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00151	0.00181	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00151	0.00181	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00151	0.00181	CcSEcCtD
Brimonidine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.0015	0.0018	CcSEcCtD
Brimonidine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.0015	0.0018	CcSEcCtD
Brimonidine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00149	0.00179	CcSEcCtD
Brimonidine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00149	0.00178	CcSEcCtD
Brimonidine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00149	0.00178	CcSEcCtD
Brimonidine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00148	0.00178	CcSEcCtD
Brimonidine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00148	0.00178	CcSEcCtD
Brimonidine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00148	0.00178	CcSEcCtD
Brimonidine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00148	0.00178	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00148	0.00177	CcSEcCtD
Brimonidine—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.00147	0.00176	CcSEcCtD
Brimonidine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00147	0.00176	CcSEcCtD
Brimonidine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00145	0.00175	CcSEcCtD
Brimonidine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00145	0.00175	CcSEcCtD
Brimonidine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.00174	CcSEcCtD
Brimonidine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00145	0.00173	CcSEcCtD
Brimonidine—Infection—Formoterol—chronic obstructive pulmonary disease	0.00145	0.00173	CcSEcCtD
Brimonidine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00143	0.00172	CcSEcCtD
Brimonidine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00143	0.00172	CcSEcCtD
Brimonidine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00143	0.00172	CcSEcCtD
Brimonidine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00143	0.00171	CcSEcCtD
Brimonidine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00143	0.00171	CcSEcCtD
Brimonidine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00143	0.00171	CcSEcCtD
Brimonidine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00142	0.00171	CcSEcCtD
Brimonidine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00142	0.0017	CcSEcCtD
Brimonidine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00142	0.0017	CcSEcCtD
Brimonidine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00142	0.0017	CcSEcCtD
Brimonidine—Infection—Montelukast—chronic obstructive pulmonary disease	0.00142	0.0017	CcSEcCtD
Brimonidine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00141	0.0017	CcSEcCtD
Brimonidine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00141	0.0017	CcSEcCtD
Brimonidine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00141	0.00169	CcSEcCtD
Brimonidine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.0014	0.00168	CcSEcCtD
Brimonidine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.0014	0.00168	CcSEcCtD
Brimonidine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00138	0.00166	CcSEcCtD
Brimonidine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00137	0.00165	CcSEcCtD
Brimonidine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00136	0.00164	CcSEcCtD
Brimonidine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00136	0.00163	CcSEcCtD
Brimonidine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00136	0.00163	CcSEcCtD
Brimonidine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00135	0.00162	CcSEcCtD
Brimonidine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.00162	CcSEcCtD
Brimonidine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.00162	CcSEcCtD
Brimonidine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00134	0.00161	CcSEcCtD
Brimonidine—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.00134	0.00161	CcSEcCtD
Brimonidine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00133	0.0016	CcSEcCtD
Brimonidine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00133	0.00159	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00133	0.00159	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00133	0.00159	CcSEcCtD
Brimonidine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00132	0.00158	CcSEcCtD
Brimonidine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00132	0.00158	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.0013	0.00156	CcSEcCtD
Brimonidine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.0013	0.00156	CcSEcCtD
Brimonidine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.0013	0.00156	CcSEcCtD
Brimonidine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00129	0.00155	CcSEcCtD
Brimonidine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00129	0.00155	CcSEcCtD
Brimonidine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00155	CcSEcCtD
Brimonidine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00154	CcSEcCtD
Brimonidine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00128	0.00154	CcSEcCtD
Brimonidine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00128	0.00154	CcSEcCtD
Brimonidine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00128	0.00154	CcSEcCtD
Brimonidine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00128	0.00153	CcSEcCtD
Brimonidine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00127	0.00152	CcSEcCtD
Brimonidine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00126	0.00152	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00126	0.00151	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00126	0.00151	CcSEcCtD
Brimonidine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00125	0.00151	CcSEcCtD
Brimonidine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.00151	CcSEcCtD
Brimonidine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00125	0.00151	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.0015	CcSEcCtD
Brimonidine—Pain—Formoterol—chronic obstructive pulmonary disease	0.00124	0.00149	CcSEcCtD
Brimonidine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00124	0.00149	CcSEcCtD
Brimonidine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00149	CcSEcCtD
Brimonidine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00148	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00123	0.00148	CcSEcCtD
Brimonidine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00123	0.00147	CcSEcCtD
Brimonidine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00122	0.00147	CcSEcCtD
Brimonidine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00122	0.00147	CcSEcCtD
Brimonidine—Pain—Montelukast—chronic obstructive pulmonary disease	0.00122	0.00146	CcSEcCtD
Brimonidine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.00145	CcSEcCtD
Brimonidine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00121	0.00145	CcSEcCtD
Brimonidine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.0012	0.00145	CcSEcCtD
Brimonidine—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.0012	0.00144	CcSEcCtD
Brimonidine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.0012	0.00144	CcSEcCtD
Brimonidine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00119	0.00143	CcSEcCtD
Brimonidine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.00119	0.00143	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00142	CcSEcCtD
Brimonidine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00142	CcSEcCtD
Brimonidine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.00141	CcSEcCtD
Brimonidine—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.00116	0.0014	CcSEcCtD
Brimonidine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00136	CcSEcCtD
Brimonidine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00136	CcSEcCtD
Brimonidine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00114	0.00136	CcSEcCtD
Brimonidine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00113	0.00136	CcSEcCtD
Brimonidine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00113	0.00136	CcSEcCtD
Brimonidine—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.00112	0.00135	CcSEcCtD
Brimonidine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00129	CcSEcCtD
Brimonidine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00129	CcSEcCtD
Brimonidine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00107	0.00129	CcSEcCtD
Brimonidine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.00107	0.00128	CcSEcCtD
Brimonidine—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00128	CcSEcCtD
Brimonidine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00126	CcSEcCtD
Brimonidine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00104	0.00125	CcSEcCtD
Brimonidine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00104	0.00125	CcSEcCtD
Brimonidine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00124	CcSEcCtD
Brimonidine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00124	CcSEcCtD
Brimonidine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00102	0.00123	CcSEcCtD
Brimonidine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00121	CcSEcCtD
Brimonidine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00101	0.00121	CcSEcCtD
Brimonidine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000991	0.00119	CcSEcCtD
Brimonidine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000986	0.00118	CcSEcCtD
Brimonidine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000972	0.00117	CcSEcCtD
Brimonidine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000965	0.00116	CcSEcCtD
Brimonidine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000962	0.00115	CcSEcCtD
Brimonidine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000962	0.00115	CcSEcCtD
Brimonidine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000942	0.00113	CcSEcCtD
Brimonidine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000917	0.0011	CcSEcCtD
Brimonidine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000917	0.0011	CcSEcCtD
Brimonidine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000916	0.0011	CcSEcCtD
Brimonidine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000916	0.0011	CcSEcCtD
Brimonidine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000911	0.00109	CcSEcCtD
Brimonidine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000911	0.00109	CcSEcCtD
Brimonidine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00091	0.00109	CcSEcCtD
Brimonidine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000908	0.00109	CcSEcCtD
Brimonidine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000898	0.00108	CcSEcCtD
Brimonidine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000898	0.00108	CcSEcCtD
Brimonidine—Depression—Prednisone—chronic obstructive pulmonary disease	0.000895	0.00107	CcSEcCtD
Brimonidine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000893	0.00107	CcSEcCtD
Brimonidine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000866	0.00104	CcSEcCtD
Brimonidine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000866	0.00104	CcSEcCtD
Brimonidine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000865	0.00104	CcSEcCtD
Brimonidine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000864	0.00104	CcSEcCtD
Brimonidine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000864	0.00104	CcSEcCtD
Brimonidine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00086	0.00103	CcSEcCtD
Brimonidine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000848	0.00102	CcSEcCtD
Brimonidine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000846	0.00102	CcSEcCtD
Brimonidine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000833	0.001	CcSEcCtD
Brimonidine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00082	0.000985	CcSEcCtD
Brimonidine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000816	0.000979	CcSEcCtD
Brimonidine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000812	0.000975	CcSEcCtD
Brimonidine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000788	0.000946	CcSEcCtD
Brimonidine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000775	0.00093	CcSEcCtD
Brimonidine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000769	0.000923	CcSEcCtD
Brimonidine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000753	0.000904	CcSEcCtD
Brimonidine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000748	0.000898	CcSEcCtD
Brimonidine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000731	0.000878	CcSEcCtD
Brimonidine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000728	0.000874	CcSEcCtD
Brimonidine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.00072	0.000864	CcSEcCtD
Brimonidine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000713	0.000855	CcSEcCtD
Brimonidine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000707	0.000849	CcSEcCtD
Brimonidine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000706	0.000847	CcSEcCtD
Brimonidine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000701	0.000842	CcSEcCtD
Brimonidine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000674	0.000809	CcSEcCtD
Brimonidine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000661	0.000794	CcSEcCtD
Brimonidine—ADRA2C—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000641	0.00435	CbGpPWpGaD
Brimonidine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000629	0.000755	CcSEcCtD
Brimonidine—ADRA2C—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.000619	0.00421	CbGpPWpGaD
Brimonidine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000617	0.00074	CcSEcCtD
Brimonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000615	0.00418	CbGpPWpGaD
Brimonidine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000606	0.000727	CcSEcCtD
Brimonidine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000597	0.000717	CcSEcCtD
Brimonidine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000597	0.000717	CcSEcCtD
Brimonidine—AOX1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000596	0.00405	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000595	0.00405	CbGpPWpGaD
Brimonidine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000595	0.000714	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000593	0.000712	CcSEcCtD
Brimonidine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00059	0.000708	CcSEcCtD
Brimonidine—ADRA2A—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000587	0.00399	CbGpPWpGaD
Brimonidine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00058	0.000697	CcSEcCtD
Brimonidine—ADRA2A—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.00058	0.00394	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—GC—chronic obstructive pulmonary disease	0.000579	0.00394	CbGpPWpGaD
Brimonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000575	0.00391	CbGpPWpGaD
Brimonidine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000572	0.000687	CcSEcCtD
Brimonidine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000569	0.000683	CcSEcCtD
Brimonidine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000563	0.000676	CcSEcCtD
Brimonidine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000561	0.000674	CcSEcCtD
Brimonidine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000559	0.000671	CcSEcCtD
Brimonidine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000556	0.000667	CcSEcCtD
Brimonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000545	0.0037	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000539	0.00366	CbGpPWpGaD
Brimonidine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000522	0.000626	CcSEcCtD
Brimonidine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000521	0.000625	CcSEcCtD
Brimonidine—ADRA2A—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.00052	0.00354	CbGpPWpGaD
Brimonidine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000518	0.000622	CcSEcCtD
Brimonidine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000514	0.000617	CcSEcCtD
Brimonidine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000504	0.000605	CcSEcCtD
Brimonidine—ADRA2A—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.000503	0.00342	CbGpPWpGaD
Brimonidine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000497	0.000596	CcSEcCtD
Brimonidine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000496	0.000596	CcSEcCtD
Brimonidine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000494	0.000592	CcSEcCtD
Brimonidine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000494	0.000592	CcSEcCtD
Brimonidine—ADRA2B—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000468	0.00318	CbGpPWpGaD
Brimonidine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000468	0.000562	CcSEcCtD
Brimonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000467	0.00317	CbGpPWpGaD
Brimonidine—ADRA2B—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.00045	0.00306	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000438	0.00297	CbGpPWpGaD
Brimonidine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000422	0.000506	CcSEcCtD
Brimonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000421	0.00286	CbGpPWpGaD
Brimonidine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000411	0.000493	CcSEcCtD
Brimonidine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000405	0.000486	CcSEcCtD
Brimonidine—ADRA2B—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000394	0.00268	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—APIP—chronic obstructive pulmonary disease	0.000392	0.00267	CbGpPWpGaD
Brimonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000386	0.00262	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000384	0.00261	CbGpPWpGaD
Brimonidine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000379	0.000454	CcSEcCtD
Brimonidine—ADRA2C—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000368	0.0025	CbGpPWpGaD
Brimonidine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000361	0.000433	CcSEcCtD
Brimonidine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000361	0.000433	CcSEcCtD
Brimonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00036	0.00245	CbGpPWpGaD
Brimonidine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000359	0.00043	CcSEcCtD
Brimonidine—ADRA2C—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000358	0.00244	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000355	0.00242	CbGpPWpGaD
Brimonidine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000352	0.00239	CbGpPWpGaD
Brimonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000345	0.00234	CbGpPWpGaD
Brimonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000342	0.00232	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000342	0.00232	CbGpPWpGaD
Brimonidine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00034	0.000408	CcSEcCtD
Brimonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000329	0.00224	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000328	0.00223	CbGpPWpGaD
Brimonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000322	0.00219	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000319	0.00217	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—APIP—chronic obstructive pulmonary disease	0.000318	0.00216	CbGpPWpGaD
Brimonidine—AOX1—Disease—HDAC2—chronic obstructive pulmonary disease	0.000318	0.00216	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000316	0.00215	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000313	0.00213	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000307	0.00209	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000306	0.00208	CbGpPWpGaD
Brimonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000302	0.00205	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000299	0.00203	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000298	0.00203	CbGpPWpGaD
Brimonidine—AOX1—Disease—KL—chronic obstructive pulmonary disease	0.000295	0.00201	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000294	0.002	CbGpPWpGaD
Brimonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000293	0.00199	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000291	0.00198	CbGpPWpGaD
Brimonidine—ADRA2B—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.000291	0.00198	CbGpPWpGaD
Brimonidine—ADRA2B—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.00029	0.00197	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000286	0.00195	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000285	0.00194	CbGpPWpGaD
Brimonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000282	0.00192	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000279	0.00189	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000276	0.00188	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000275	0.00187	CbGpPWpGaD
Brimonidine—ADRA2C—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.000272	0.00185	CbGpPWpGaD
Brimonidine—ADRA2C—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.000271	0.00184	CbGpPWpGaD
Brimonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000267	0.00182	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000265	0.0018	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000263	0.00179	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000263	0.00179	CbGpPWpGaD
Brimonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000262	0.00178	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00026	0.00177	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000259	0.00176	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000258	0.00175	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—GC—chronic obstructive pulmonary disease	0.000253	0.00172	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000249	0.00169	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000247	0.00168	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000245	0.00167	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.00024	0.00163	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000235	0.0016	CbGpPWpGaD
Brimonidine—ADRA2B—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000234	0.00159	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000232	0.00158	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000232	0.00158	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.00023	0.00156	CbGpPWpGaD
Brimonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000229	0.00156	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000226	0.00154	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000225	0.00153	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000223	0.00152	CbGpPWpGaD
Brimonidine—AOX1—Disease—ERBB3—chronic obstructive pulmonary disease	0.000221	0.0015	CbGpPWpGaD
Brimonidine—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.000221	0.0015	CbGpPWpGaD
Brimonidine—ADRA2A—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.00022	0.0015	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000219	0.00149	CbGpPWpGaD
Brimonidine—ADRA2C—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000219	0.00149	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000217	0.00148	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000216	0.00147	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000215	0.00146	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000211	0.00143	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.00021	0.00142	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—GC—chronic obstructive pulmonary disease	0.000205	0.0014	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000202	0.00137	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000201	0.00137	CbGpPWpGaD
Brimonidine—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.0002	0.00136	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000199	0.00135	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000197	0.00134	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000194	0.00132	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000191	0.0013	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000191	0.0013	CbGpPWpGaD
Brimonidine—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000187	0.00127	CbGpPWpGaD
Brimonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000186	0.00127	CbGpPWpGaD
Brimonidine—AOX1—Disease—NOS2—chronic obstructive pulmonary disease	0.000185	0.00125	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000184	0.00125	CbGpPWpGaD
Brimonidine—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000184	0.00125	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000182	0.00124	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000181	0.00123	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000178	0.00121	CbGpPWpGaD
Brimonidine—ADRA2A—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000178	0.00121	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000176	0.0012	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000176	0.0012	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000174	0.00119	CbGpPWpGaD
Brimonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000174	0.00118	CbGpPWpGaD
Brimonidine—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000171	0.00117	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000166	0.00113	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000166	0.00113	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000165	0.00112	CbGpPWpGaD
Brimonidine—AOX1—Disease—SERPINE1—chronic obstructive pulmonary disease	0.000155	0.00106	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000155	0.00105	CbGpPWpGaD
Brimonidine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000152	0.00103	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000151	0.00103	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.00015	0.00102	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.00015	0.00102	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—ALB—chronic obstructive pulmonary disease	0.00015	0.00102	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000148	0.00101	CbGpPWpGaD
Brimonidine—AOX1—Disease—NOS3—chronic obstructive pulmonary disease	0.000148	0.00101	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000147	0.000999	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000143	0.000973	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000142	0.000966	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000142	0.000965	CbGpPWpGaD
Brimonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000141	0.000961	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000141	0.000958	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.00014	0.000952	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—ALB—chronic obstructive pulmonary disease	0.00014	0.00095	CbGpPWpGaD
Brimonidine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000139	0.000947	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000139	0.000942	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000138	0.000938	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000136	0.000927	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000135	0.000918	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000135	0.000916	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000134	0.000909	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000134	0.000909	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000133	0.000902	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000133	0.000901	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—ALB—chronic obstructive pulmonary disease	0.00013	0.000883	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.00013	0.000883	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000126	0.000857	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000126	0.000856	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000124	0.000846	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000124	0.000845	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000121	0.000824	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000118	0.000802	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000115	0.00078	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000114	0.000778	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000114	0.000773	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000113	0.000772	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000113	0.000766	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000112	0.000762	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000111	0.000753	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.00011	0.000749	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000109	0.000738	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000108	0.000733	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000108	0.000732	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000104	0.000706	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000103	0.000701	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000102	0.000695	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000101	0.000687	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	9.85e-05	0.00067	CbGpPWpGaD
Brimonidine—AOX1—Disease—TGFB1—chronic obstructive pulmonary disease	9.81e-05	0.000667	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.7e-05	0.000659	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	9.65e-05	0.000656	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—VEGFA—chronic obstructive pulmonary disease	9.63e-05	0.000655	CbGpPWpGaD
Brimonidine—AOX1—Disease—EGFR—chronic obstructive pulmonary disease	9.62e-05	0.000654	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.57e-05	0.00065	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—TGFB1—chronic obstructive pulmonary disease	9.46e-05	0.000643	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.44e-05	0.000641	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.32e-05	0.000633	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—KL—chronic obstructive pulmonary disease	9.02e-05	0.000613	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	8.95e-05	0.000608	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.91e-05	0.000606	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—TGFB1—chronic obstructive pulmonary disease	8.84e-05	0.000601	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.79e-05	0.000598	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.33e-05	0.000567	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.32e-05	0.000566	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.02e-05	0.000545	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.96e-05	0.000541	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.88e-05	0.000536	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	7.82e-05	0.000532	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—TP53—chronic obstructive pulmonary disease	7.79e-05	0.00053	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.77e-05	0.000528	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.66e-05	0.000521	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.49e-05	0.000509	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.44e-05	0.000506	CbGpPWpGaD
Brimonidine—AOX1—Disease—IL6—chronic obstructive pulmonary disease	7.39e-05	0.000503	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.32e-05	0.000498	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.28e-05	0.000495	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—TP53—chronic obstructive pulmonary disease	7.28e-05	0.000495	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.24e-05	0.000492	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	7.18e-05	0.000488	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.14e-05	0.000485	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.96e-05	0.000473	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.8e-05	0.000463	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.77e-05	0.00046	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.76e-05	0.00046	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.76e-05	0.00046	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.51e-05	0.000442	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.48e-05	0.00044	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.09e-05	0.000414	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.05e-05	0.000411	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.04e-05	0.000411	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	5.91e-05	0.000402	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—ALB—chronic obstructive pulmonary disease	5.67e-05	0.000385	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.53e-05	0.000376	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.49e-05	0.000373	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—NOS3—chronic obstructive pulmonary disease	5.42e-05	0.000368	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.32e-05	0.000362	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.28e-05	0.000359	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.08e-05	0.000345	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.97e-05	0.000338	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.91e-05	0.000334	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.85e-05	0.00033	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.75e-05	0.000323	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	4.6e-05	0.000313	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.53e-05	0.000308	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	4.4e-05	0.000299	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.3e-05	0.000293	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.09e-05	0.000278	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.04e-05	0.000275	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.02e-05	0.000273	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.89e-05	0.000265	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.86e-05	0.000262	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.82e-05	0.00026	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.68e-05	0.00025	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.64e-05	0.000247	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.49e-05	0.000238	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.26e-05	0.000222	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.26e-05	0.000222	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.21e-05	0.000218	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.15e-05	0.000214	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.1e-05	0.000211	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3e-05	0.000204	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.95e-05	0.000201	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.94e-05	0.0002	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.65e-05	0.00018	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.64e-05	0.00018	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.47e-05	0.000168	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.43e-05	0.000165	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.42e-05	0.000164	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.39e-05	0.000162	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.26e-05	0.000153	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2e-05	0.000136	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.83e-05	0.000125	CbGpPWpGaD
